Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390;
机译:酯酶激活的β-拉帕酮前药胶束用于靶向NQO1的肺癌
机译:Irinotecan通过单分子胶束递送由高药物载荷的减少响应星形聚合物前药,用于增强癌症治疗
机译:酸活化的硫替氏纤维素,由具有高药物载荷的两亲性星形聚合物前药组成,用于增强癌症治疗
机译:高负荷β-leapachone前药胶束的研制,用于NQO1特异性癌症治疗
机译:前药的发展和活性氧在β-拉帕酮介导的细胞死亡中的作用。
机译:酯酶激活的β-拉帕酮前药胶束用于NQO1靶向的肺癌治疗
机译:用于NQO1靶向肺癌疗法的酯酶 - 可活化β-乙酰酮前药胶束
机译:开发用于治疗NQ01-过度表达乳腺癌的β-Lapachone前药